Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Settlement Between Pfizer and Teva on Generic Zyvox is a Significant Positive for Trius Therapeutics

The Issue
On May 31, 2012, Pfizer Inc. (PFE) and Teva (TEVA reached a settlement that licenses to Teva a generic…
Read more…

Generic Challenge to Pfizer's EpiPen by Teva and Antares (AIS, $2.70)

EpiPen is a self-administered injection of epinephrine used to avert anaphylactic shock following a severe allergic reaction, as with a…
Read more…

Initiation Report on a Cheap Lumbering Stock (PFE, $20.78)

Pfizer is entering a patent cliff period in which sales will decline over the next two years. The drug pipleline…
Read more…